Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- TERMINATED
- Phase
- PHASE3
Clinical Trials Related to Nab-paclitaxel
Related studies linked through entity extraction aliases.
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Rollover Study to Provide Continued Access to Napabucasin for Patients Enrolled in Boston Biomedical-sponsored Protocols
- Status
- COMPLETED
- Phase
- PHASE1
CompassHER2-pCR: Decreasing Chemotherapy for Breast Cancer Patients After Pre-surgery Chemo and Targeted Therapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss
- Status
- TERMINATED
- Phase
- PHASE3
Cryoablation, Atezolizumab/Nab-paclitaxel for Locally Advanced or Metastatic Triple Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- EARLY_PHASE1
Nivolumab, Ipilimumab and Chemoradiation in Pancreatic Cancer.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of SY 5609, a Selective CDK7 Inhibitor, in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Randomised Trial of ATRA in a Novel Drug Combination for Pancreatic Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of Pralsetinib Versus Standard of Care for First-Line Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC)
- Status
- TERMINATED
- Phase
- PHASE3
Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations
- Status
- TERMINATED
- Phase
- PHASE2
Nab-paclitaxel Versus Topotecan As Second-Line Treatment for Patients With Extensive Stage Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Platinum-Based Chemotherapy With/Without INCMGA00012, an Anti-PD-1 Antibody, in Non-Small Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of ABBV-368 Plus Tilsotolimod and Other Therapy Combinations in Participants With Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1
Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Nab-Paclitaxel in Patients With ER+/HER2- Recurrent Metastatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1